region earn 2nd quarter net incom soar 266 amgen amgen inc thousand oak biotechnolog compani said net incom soar 266 14 3 million second quarter end sept 30 3 9 million year amgen attribut huge jump sale drug treatment chronic anemia kidney dialysi patient drug call epogen approv sale food drug administr june 1989 amgen said total revenu second quarter nearli doubl 78 8 million 39 6 million last year first half amgen fiscal year compani profit increas fivefold 25 5 million 4 7 million year ago amgen six month sale doubl 150 5 million 68 1 million